Alnylam Pharmaceuticals Announces the Termination of its RNAi Collaboration with Merck

News   Sep 20, 2007

 
Alnylam Pharmaceuticals Announces the Termination of its RNAi Collaboration with Merck
 
 
 

RELATED ARTICLES

CRISPR Causes More Genome Damage Than First Thought

News

Researchers have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.

READ MORE

Finding the Proteins That Unpack DNA

News

A new method allows researchers to systematically identify specialized proteins that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.

READ MORE

Land Genes in Algae Identified

News

500 million years ago, the first plants living in water took to land. The genetic adaptations associated with this transition can already be recognized in the genome of Chara braunii, a species of freshwater algae, reports a new study.


READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy